2019
DOI: 10.1183/13993003.01914-2018
|View full text |Cite
|
Sign up to set email alerts
|

Pulmonary hypertension in chronic lung disease and hypoxia

Abstract: Pulmonary hypertension (PH) frequently complicates the course of patients with various forms of chronic lung disease (CLD). CLD-associated PH (CLD-PH) is invariably associated with reduced functional ability, impaired quality of life, greater oxygen requirements and an increased risk of mortality. The aetiology of CLD-PH is complex and multifactorial, with differences in the pathogenic sequelae between the diverse forms of CLD. Haemodynamic evaluation of PH severity should be contextualised within the extent o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

15
617
1
55

Year Published

2019
2019
2024
2024

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 541 publications
(688 citation statements)
references
References 89 publications
15
617
1
55
Order By: Relevance
“…25 mmHg with cardiac index < 2.0 L.min -1 .m -2 ) as defined by Nice 2018 criteria. 4 Treatment for 'IPAH lung disease ' and 'IPAH no lung disease '…”
Section: Demographics Pulmonary Function and Haemodynamicsmentioning
confidence: 99%
“…25 mmHg with cardiac index < 2.0 L.min -1 .m -2 ) as defined by Nice 2018 criteria. 4 Treatment for 'IPAH lung disease ' and 'IPAH no lung disease '…”
Section: Demographics Pulmonary Function and Haemodynamicsmentioning
confidence: 99%
“…An effect of nintedanib on pulmonary hypertension cannot be excluded, as previously reported (18). Our patient's worsening pulmonary hypertension coincided with a declining forced vital capacity, so was attributed to chronic lung disease (19). We therefore treated his lung disease with drugs and oxygen therapy, but did not treat his pulmonary arterial hypertension pharmacologically.…”
Section: Discussionmentioning
confidence: 55%
“…Current guidelines recommend the use of end-expiratory pressure in the evaluation of left heart disease 49 and computer averaging in patients with parenchymal lung disease. 50 In patients that have wide respiratory variations, we find it is most helpful to report both values together to provide a complete picture (see right heart catheterization [RHC]) template, online supplement).…”
Section: Discussionmentioning
confidence: 99%